ATAP Advocates
Taking a Stand For Patients

State Advocacy

State Advocacy

ATAP’s strategy at the state level is two-fold:

  1. Identify states that may be interested in ATAP PBM transparency state model bill and actively work with lawmakers and other stakeholders in those states to implement it.
  2. Track and support PBM-related state bills introduced this session.

The state policy team has developed a state model bill that focuses on mandated disclosures and increased state regulation of PBMs and is working in multiple states to get a version of the model introduced in the legislatures.  Please contact ATAP staff for more information.

Track the latest PBM state legislation here >>

Featured
Commentary by Dr. Robert Levin: New law removes the veil over rising prescription drug costs

Americans spend more per capita on prescription drugs than any other high-income country in the world. Many states have wrestled with the rising costs of these medications, particularly in Florida.

Read More →
State Advocacy Roundup - PBM Bills Continue to Progress in Numerous Key States

State efforts to address harmful PBM practices are continuing to gain momentum across the country, with numerous states considering PBM-related legislation this session.  Here are some recent state advocacy highlights:

Read More →
Colorado Passes ATAP-Supported PBM Bill, Now Headed to Governor

ATAP is once again pleased to report that Colorado passed a bill (HB 1284) last week aimed at regulating PBMs, the latest in the growing movement sweeping across the nation. 

Read More →
ATAP Applauds New PBM Legislation in Arizona

ATAP is pleased to report that an Arizona bill aimed at regulating PBMs was passed through the legislature unanimously, and was signed into law by Governor Ducey on April 5.

Read More →